関連する実験動画
Updated: Feb 8, 2026

10:37
Covalent Attachment of Single Molecules for AFM-based Force Spectroscopy
Published on: March 16, 2020
10.3K
小分子共性阻害剤によるSTINGの標的化
Simone M Haag1, Muhammet F Gulen1, Luc Reymond2
1Global Health Institute, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
Nature
|July 6, 2018
まとめ
研究 者 たち は,先天 的 な 免疫 の 中 で 重要な 役割 を 果たす インターフェロン 遺伝子 (STING) の 刺激 タンパク質 を 阻害 する 小さな 分子 を 発見 し まし た. これらのSTING阻害剤は炎症を軽減し,自己炎症性疾患の治療の可能性を示しています.
科学分野:
- 免疫学
- 分子生物学
- 薬物の発見
背景:
- 異常な先天性免疫経路の活性化は様々な病気と関連しています
- 生まれつきの免疫に対する標的治療は有望ですが 開発は困難です
- インターフェロン遺伝子の刺激剤 (STING) タンパク質は細胞内DNAセンシングの重要な媒介です.
研究 の 目的:
- STINGタンパク質の新しい小分子抗体を発見し,特徴づけること.
- STING抗体がその機能を阻害するメカニズムを解明する.
- 自己炎症疾患のモデルにおけるSTING抑制の治療の可能性を評価する.
主な方法:
- 小分子STING抗薬の発見と特徴付け
- システイン91を標的とし,パルミトイレーションを阻害するなど,STING抑制メカニズムの調査.
- STING阻害剤がヒトとマウスの細胞におけるサイトカインの産生を抑制する効果の評価
- 自発炎症疾患のマウスモデルにおけるSTING抗薬の評価
主要な成果:
- 強力で選択的な小分子STING抗剤の特定
- これらの化合物が共性的にシステイン91を標的とし,STINGのパルミトイレーションを抑制することを示す.
- STINGのパルミトイロ化がマルチメリック複合体の組み立てと下流シグナル伝達に不可欠であるという証拠
- STING媒介の炎症性サイトカインの産生を in vitro で減少させる.
- 自己炎症性疾患のマウスモデルにおける病理学的特徴の弱化
結論:
- STINGのパルミトイレーションは,その機能に不可欠であり,薬学的に抑制することができます.
- 小分子STING抗薬は,自己炎症性疾患の有望な治療戦略です.
- この研究はSTING抑制と治療への応用のための新しいメカニズムを提供します.
関連する概念動画
Covalent Bonds
163.2K
Overview
163.2K
Covalent Bonds
11.4K
Overview
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
When two atoms share electrons to complete their valence shells, they create a covalent bond. An atom's electronegativity—the force with which shared electrons are pulled towards an atom—determines how the electrons are shared. Molecules formed with covalent bonds can be either polar or nonpolar. Atoms with similar electronegativities form nonpolar covalent bonds; the electrons are shared equally. Atoms with different electronegativities share electrons unequally,...
11.4K
Covalent Bonding and Lewis Structures
61.5K
Compared to ionic bonds, which results from the transfer of electrons between metallic and nonmetallic atoms, covalent bonds result from the mutual attraction of atoms for a “shared” pair of electrons.
61.5K
Network Covalent Solids
16.2K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.2K
Covalently Linked Protein Regulators
9.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
9.6K
Covalently Linked Protein Regulators
2.0K
2.0K

